|
- Shaping the Future of Oncology for Patients l Exelixis
At Exelixis, cancer is our cause Over the course of the past three decades, we’ve evolved into a multi-platform cancer company dedicated to creating treatment regimens that challenge the status quo and bring us closer to a potential cure – all to give more patients hope for the future
- Cancer Clinical Trials and Pipeline l Exelixis
* Sairopa B V (Sairopa) and Exelixis have an exclusive clinical development and option agreement providing Exelixis the right to acquire ADU-1805 ** Merck is sponsoring the study, and Exelixis is supplying the study drug, zanzalintinib
- Investors and News | Exelixis
Exelixis is expanding its global innovation engine to evolve how cancer is treated and deliver for physicians, patients and partners
- Our Medicines for Cancer Patients l Exelixis
If you are a healthcare professional and have a question about an Exelixis product, please contact Exelixis Medical Information at medinfo@exelixis com or call 1-855-292-3935 (EXEL)
- Search Careers at Exelixis
We are aware of fraud or scams from individuals, organizations and or internet sites claiming to represent Exelixis in recruitment activities Please know that we have an established recruitment process for all posted positions by Exelixis prior to issuing an offer of employment
- Advancing Science for Cancer Treatments l Exelixis
Inside Exelixis Advancing science for hope We are driven by a singular focus to bring life-enhancing cancer treatments to patients Powered by drug discovery and development excellence, we are thinking bigger and broader than ever before to expand our product portfolio and propel oncology innovation forward
- Evolving How Cancer is Treated l Exelixis
I am energized by scientific learnings that lead to understanding, and I’m excited to work with my team to bring the next generation of Exelixis medicines to patients
- Accelerating New Medicines for Cancer l Exelixis
Developing new medicines is an iterative process After testing potential compounds in labs and selecting drug candidates to study further, Exelixis conducts research and clinical trials to compile data on the safety and efficacy of each potential medicine
|
|
|